tonrice1
About
Neutralizing Antibodies towards SARS-CoV-2, Anti-Ad5 Antibodies, along with Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in People who have along with with out Prior SARS-CoV-2.
Neutralizing Antibodies towards SARS-CoV-2, Anti-Ad5 Antibodies, along with Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in People who have along with with out Prior SARS-CoV-2.